[Acute myelogenous leukemia. When the choice is between a good and a bad death].
作者信息
Hjort P F, Stavem P, Evensen S A
出版信息
Sykepleien. 1986 Jan 24;73(2):23-5, 29.
PMID:3082030
Abstract
摘要
相似文献
1
[Acute myelogenous leukemia. When the choice is between a good and a bad death].
Sykepleien. 1986 Jan 24;73(2):23-5, 29.
2
Cutting the suit according to the cloth.
Health Serv J. 1986 Jun 26;96(5005):suppl 1-3.
3
Use of healthcare resources in the last six months of life: findings should be approached with caution outside United States.
BMJ. 2004 May 15;328(7449):1201; author reply 1202. doi: 10.1136/bmj.328.7449.1201-b.
4
We need to ration medicine.
Newsweek. 1982 Feb 8;99(6):13.
5
Rationing health care: the British experience in the 1980s.
Front Health Serv Manage. 1987 Feb;3(3):4-44.
6
Case management. A means to improve quality and control the costs of cure in children with acute myelogenous leukemia.
J Pediatr Hematol Oncol. 1995 Aug;17(3):248-53. doi: 10.1097/00043426-199508000-00006.
7
NCCN Practice Guidelines for Acute Myelogenous Leukemia.
Oncology (Williston Park). 2000 Nov;14(11A):53-61.
8
Economic burden associated with acute myeloid leukemia treatment.
Expert Rev Hematol. 2016 Jan;9(1):79-89. doi: 10.1586/17474086.2016.1112735. Epub 2015 Nov 14.
9
Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
Appl Health Econ Health Policy. 2013 Jun;11(3):275-86. doi: 10.1007/s40258-013-0032-2.
10
[Cost effectiveness in treatment of acute myeloid leukemia].
Schweiz Med Wochenschr. 2000 Dec 23;130(51-52):1994-2000.
Zotero 插件